Inflammatory arthritis Musculoskeletal Diseases
Conditions
Interventions
The PAIN PATH survey involves patients with inflammatory arthritis completing a one-off questionnaire online (or alternatively on paper for those taking part at their local hospital).
The PAIN PATH L
Sponsors
Keele University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: REGIONAL RECRUITMENT For both studies, patients will be included that are: 1. Aged >= 18 years 2. Have a clinical diagnosis of RA, PsA or axial SpA 3. Provide consent. Additionally, for the longitudinal study patients will be included that: 1. Have completed the PAIN PATH Survey 2. Have mobile-phone access 3. Currently use an analgesic that can be taken at least twice a day (as per their understanding of their prescription) 4. Report currently using analgesics at least once a week (to allow drivers of analgesic use to be examined). NATIONAL RECRUITMENT For both studies, patients will be included that are: 1. Aged >= 18 years 2. Have a self-reported diagnosis of RA, PsA or axial SpA 3. Provide consent 4. Have internet access and an email address, and (e) receive care in one of the UK National Health Services. Additionally, for the longitudinal study patients will be included that: 1. Have completed the PAIN PATH Survey 2. Report using analgesics in the last month
Exclusion criteria
Exclusion criteria: 1. For both studies those patients who enroll via the national recruitment pathway will not also be able to participate in the regional study (and vice versa) to avoid people taking part in the study on more than one occasion. 2. For the longitudinal study the SMS-messages and Portal have questions that are written in English, which are answered remotely on multiple occasions. Consequently, patients who cannot respond to written English themselves, and are unable to access translation support from a relative, friend or carer, will not be able to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PAIN PATH survey questionnaire completed at a single time point: 1. Pain severity – evaluated using the simplified Graded Chronic Pain Scale Revised (GCPS-R), measured in the regional/national survey at NHS sites or on paper/online by the participant. 2. Fibromyalgia – its presence or absence will be established using the Widespread Pain Index and Symptom Severity Score, allowing diagnostic criteria to be applied measured in the regional/national survey at NHS sites or on paper/online by the participant. 3. Pain trajectories – the Visual Trajectories Questionnaire-Pain (VTQ-P) will ask patients to classify their pain experience into one of a number of trajectories using visual and word descriptions. measured in the regional/national survey at NHS sites or on paper/online by the participant. 4. Pain Assessments-n As EULAR guidelines recommend a broad range of pain assessment components it is unfeasible to assess all of these within the questionnaire. We therefore prioritized the following for evaluation, which represent core aspects of pain assessments: 5.1. assessment of pain severity. 5.2. invitation for patients to disclose the impact of pain on their daily functioning. 5.3. assessment of patients’ ideas and concerns regarding the cause of their pain. 5.4. consideration of patients’ expectations for treatment. 5.5. consideration of patients’ preferences for treatment. 5.6. assessment of previous pain treatments and their effects. 5.7. assessment of pain-related factors that may need attention (questions 2H, considering mood, and 2I, considering sleep). 5. Pain Management - A further series of bespoke questions developed for this survey will assess pain management against EULAR guidelines measured in the regional/national survey at NHS sites or on paper/online by the participant. 6. The Beliefs About Medicines Questionnaire (BMQ) will evaluate patients’ beliefs about their pain medicines measured in the regional/national survey at NHS sites or on paper/online by | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
England, Northern Ireland, Scotland, United Kingdom, Wales
Outcome results
None listed